Ernesto Martín-Núñez

🔬 Back at the #Biomarkers Annual Meeting in Cannes this weekend! 🫀✨ Our PI Natalia López sharing insights during “Novel Pathophysiological Insights in Heart Failure: Focus on Omics and Biomarkers” session. Always a pleasure to reconnect the community 🤝🚀

🇧🇪 Leuven delivered! Last weekend at #FCVB2026, our PI Eva Jover represented the group at the forefront of cardiovascular biology 🫀 Inspiring science, fresh ideas, and great exchanges with colleagues. Thanks @escardio for a fantastic meeting!

🚀 Another year at the #HVS2026 Meeting in Chicago! 🫀 A few days full of cutting-edge science 🫀, meaningful networking 🤝, and new collaborations ahead. We keep building, learning, and moving forward! #HVS #HeartValveDisease @HeartValveOrg

Great talk by @MiriamGoni1 in the PhD student seminars at @navarrabiomed about her work "Chemerin as a sex-specific target in aortic stenosis associated with diabetes, regulated by the aldosterone/mineralocorticoid receptor axis". Congrats Miriam!! 😊👏👏

Ha costado, pero por fin está aquí!!! Último paper con resultados de mi tesis y el inicio de una línea en Pamplona. Long overdue but worth it!

¡Y recuerda! Tú también puedes impulsar la investigación. 🔬📖 Si quieres apoyar nuestro trabajo, puedes colaborar con el área de Cardiología Traslacional de @navarrabiomed 👇🏻 🔗colabora.navarrabiomed.es/investigacion Cada contribución nos ayuda a avanzar. 🫀👩🏻‍🔬🧑🏻‍⚕️

🗣️La ciencia también se construye en diálogo con los pacientes. Esta tarde nuestra IP Natalia López ha compartido con @ANADInavarra nuestro trabajo, hablando sobre cómo la perspectiva de sexo y género nos ayuda a llegar a todo el mundo. 🫀🔬 #LaCienciadel100 💯

📢 Postdoctoral Opportunity in Canarias. We are seeking a postdoctoral candidate to apply for the Sara Borrell Fellowship (ISCIII), 3 years postdoc funding, in the 2026 upcoming call (starts on Jan 2027 if funded). isciii.es/financiacion/a…

Thrilled to have attended the INI-CRCT 2025 Scientific Meeting in Monaco! 🌍✨ Our PI Natalia represented our group, strengthening collaborations and sharing our ongoing research within this outstanding network. Proud to keep contributing to INI-CRCT! inicrct.fr/2025/11/27/mee…

Cannot not share this 😅

How to respond to reviewers

Muy bien Mattie!!!! 💪🏻

"I watched my advisor publish 21 papers in 1 year. Meanwhile, I spent 8 months on a single study that might never see daylight. I felt like I was failing at academia." A PhD friend told me yesterday ⤴️ Then she shared what changed her perspective completely. Those 21 papers were strategic collaborations solving critical problems across multiple fields. Her single study? That was preventing outbreaks in rural communities! She realized she was comparing apples to oranges. This and other conversations with my PhD friends taught me something important about research careers: 𝗧𝗵𝗲𝗿𝗲 𝗮𝗿𝗲 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗽𝗮𝘁𝗵𝘀 𝘁𝗼 𝗶𝗺𝗽𝗮𝗰𝘁: → The deep-dive specialist (months/years on one breakthrough) → The strategic collaborator (connecting dots across projects) → The methodology expert (enabling others' discoveries) → The translator (making research accessible and actionable) Quality research isn't about doing less work. It's about doing purposeful work ⤴️ whether that's deep solo research or strategic collaboration. --------------------- 𝗥𝗲𝗹𝗮𝘁𝗮𝗯𝗹𝗲? 🔄 Retweet (& like) Follow @RaziaAliani to get more useful Research content in your feed. Get FREE exclusive tips on using AI in research: 🔗 link in bio

Gracias a @SENefrologia por invitarnos un año más para presentar nuestros trabajos en el #senefro25 @SanidadGobCan #HospitalNuestraSeñoradeCandelaria @ITB_ULL @EMN87 @Victagua

Excited to be once again in the #ESACMeeting and share our latest research! 🌍 Our PI Dr Natalia López presented our advances on the Aldo/MR pathway in valvular heart disease, highlighting key sex-related differences. 👨🏻‍🦱👱🏼‍♀️

Enhorabuena amigo!!

3️⃣ Segundo AES-LEIS 2025 del @SaludISCIII, liderado por Ernesto Martín (@EMN87) y Adela Navarro (@echeve_adela): 👉 “Impacto de las alteraciones en el eje FGF23/Klotho sobre la progresión de la estenosis aórtica calcificante en la ERC y posibles beneficios de los iSGLT2.”

✨¡Estamos de enhorabuena! 🪙Este 2025 nuestro grupo ha conseguido 3 proyectos nacionales que nos permitirán seguir investigando para mejorar la salud cardiovascular 🫀🔬. @navarrabiomed @idisnanavarra

📢 ¡Ya tenemos nueva doctora! 👩🏼‍🎓 Enhorabuena @AmaiaGPU por una brillante defensa de tesis doctoral. ¡Estamos muy orgullosos! 🎉👏🏼

🎓✨Cuenta atrás para la defensa de tesis doctoral de @AmaiaGPU “Estudio histopatológico de la valvulopatía mitral primaria. Mecanismos patogénicos moleculares y estudio del sistema IL-33/ST2 como nueva diana terapéutica.” 📅Viernes 5/09 🕚11:00h 📍Salón de Actos, Navarrabiomed